Nokea
Which of the following statements CORRECTLY describes the mechanism of action of imatinib mesylate in chronic myeloid leukemia:
- A. Inhibitor of tyrosine kinase
- B. Inhibitor of topoisomerase 1
- C. Inhibitor of topoisomerase 2
- D. It is an alkylating agent
Correct Answer: A
Rationale: Imatinib inhibits BCR-ABL tyrosine kinase in CML.
You may also like to solve these questions
Which of the following avoids first pass effect of drugs
- A. Oral ingestion
- B. Rectal Suppository
- C. Intra venous injection
- D. Intra-arterial injection
Correct Answer: D
Rationale: Intra-arterial injection bypasses the liver, avoiding first-pass metabolism.
Low doses of aspirin prolong bleeding time by selectively inhibiting synthesis of the following mediator in the platelets:
- A. Thromboxane Aâ‚‚
- B. 5-Hydroxytryptamine
- C. Platelet activating factor
- D. Prostacyclin
Correct Answer: A
Rationale: Low-dose aspirin irreversibly inhibits COX-1 in platelets, reducing thromboxane Aâ‚‚ production, which promotes platelet aggregation, thus prolonging bleeding time.
Which of the following statements about pancreatic enzymes is true?
- A. Dosing may be titrated according to the decrease of steatorrhea
- B. The amount of carbohydrates in the meal drives the amount of enzyme used
- C. The amount of medication used is increased with a cystic fibrosis pulmonary flare
- D. The FDA and Internet-available formulations are bioequivalent
Correct Answer: A
Rationale: Pancreatic enzyme dosing adjusts based on steatorrhea reduction; carbs aren't the driver, and flares don't increase it.
Patients with pernicious anemia require treatment with:
- A. Iron
- B. Folic acid
- C. Epogen alpha
- D. Vitamin B12
Correct Answer: D
Rationale: Pernicious anemia requires vitamin B12 due to absorption deficiency; folate masks it without correcting neuropathy.
Adherence is improved when a drug can be given once daily. Which of the following drugs can be given once daily?
- A. Tacrine
- B. Donepezil
- C. Memantine
- D. Pyridostigmine
Correct Answer: B
Rationale: Donepezil's long half-life allows once-daily dosing, improving adherence.